HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DUALITYBIO-B

194.500

+6.8003.62%

Volume:708.54K

Turnover:135.96M

Market Cap:17.67B

PE:-4.89

High:198.300

Open:189.200

Low:182.300

Close:187.700

52wk High:563.500

52wk Low:158.500

Shares:90.82M

HK Float Shares:90.82M

Volume Ratio:0.73

T/O Rate:0.78%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-39.800

ROE:-1282.14%

ROA:-9.61%

PB:6.24

PE(LYR):-4.89

PS:8.18

Loading ...

Overview Company News Filings

Dualitybio Announces China Nmpa Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic Her2-Positive Adult Breast Cancer

THOMSON REUTERS

DUALITYBIO-B's New Drug Application for HER2-Positive Breast Cancer Accepted by NMPA

BRIEF-Duality Biotherapeutics Says NMPA Accepts Biologics License Application For Db-1303/Bnt323

Duality Biotherapeutics Inc - Nmpa Accepts Biologics License Application for Db-1303/Bnt323 in Her2-Positive Breast Cancer

THOMSON REUTERS

Duality Biotherapeutics says China NMPA accepts BLA for DB-1303 in HER2+ breast cancer

Duality Biotherapeutics Sets 24–29 April 2026 Book Closure for Extraordinary General Meeting

Bulletin Express

Duality Biotherapeutics announces extraordinary general meeting

HK Pharma Stocks Gained. CSPC Pharma Up 13%; Lepu Bio Up 7%; Hengrui Pharma And Junshi Bio Up 6%; HBM, Beigene, Sihuan Pharm Up 5%

Tiger Newspress

DualityBio-B Maintains Outperform Rating with HK$430 Target from CICC

Stock Track | Duality Biotherapeutics Soars 5% Intraday as Analysts Boost Estimates After Earnings Report

Earnings Update: Duality Biotherapeutics, Inc. (HKG:9606) Just Reported And Analysts Are Boosting Their Estimates

Simply Wall St.

HK Pharma Stocks Gained. XuanzhuBio Up 9%; Xtalpi, Lepu Bio And Ascletis Up 6%; Akeso Up 5%; Skb Bio Up 4%.

Tiger Newspress

Dualitybio (9606.HK) Announces 2025 Annual Results

THOMSON REUTERS

Press Release: DualityBio (9606.HK) Announces 2025 Annual Results

Stock Track | Duality Biotherapeutics Plummets 5.04% Intraday on Widened 2025 Loss and Revenue Decline

HK Pharma Stocks Gained. Wuxi XDC Up 8%; Wuxi AppTec Up 7%; Transthera And HBM Up 5%; Keymed Bio And Innocare Up 4%; Wuxi Bio And Remegen Up 3%

Tiger Newspress

BRIEF-Duality Biotherapeutics FY Revenue Rmb1.85 Billion

BRIEF-Duality Biotherapeutics Inc Says Si Wen Tendered Resignation As Exec Director

DUALITYBIO-B Reports 2025 Revenue of Approximately 18.52 Billion Yuan, Marking Significant Pipeline and Operational Progress

DualityBio Posts Wider 2025 Loss on Fair-Value Impact; Core ADC Programs Advance Toward Commercial Stage

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/09606/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"09606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"DUALITYBIO-B","latestPrice":194.5,"timestamp":1787299688006,"preClose":187.7,"halted":0,"volume":708535,"delay":0,"changeRate":0.03622802344166229,"floatShares":90824200,"shares":90824200,"eps":-39.8,"marketStatus":"Not Yet Opened","change":6.8,"latestTime":"08-21 16:08:08","open":189.2,"high":198.3,"low":182.3,"amount":135955619,"amplitude":0.085242,"askPrice":194.6,"askSize":600,"bidPrice":194.4,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-31.631,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":187.7,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.7250757174044793,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","floatShares":90824200,"roa":"-9.61%","roe":"-1282.14%","lyrEps":-39.8,"volumeRatio":0.7250757174044793,"shares":90824200,"dividePrice":0,"high":198.3,"amplitude":0.085242,"preClose":187.7,"low":182.3,"week52Low":158.5,"pbRate":"6.24","psRate":"8.18","week52High":563.5,"institutionHeld":0,"latestPrice":194.5,"committee":-0.5,"eps":-39.8,"divideRate":0,"volume":708535,"delay":0,"ttmEps":-31.631,"open":189.2,"prevYearClose":298.2,"prevWeekClose":192.6,"prevMonthClose":181.8,"prevQuarterClose":181.2,"fiveDayClose":192.6,"twentyDayClose":234.2,"sixtyDayClose":223,"earningDate":1787846400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09606\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-23","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-26","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09606\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09606\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1783440000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09606\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09606","date":"2026-08-21","current":-6.149031,"percent":0.906627,"low":-29.984477,"twenty":-16.354018,"median":-9.310353,"eighty":-6.918832,"high":-4.703556,"avg":-11.684236,"sd":6.231586,"marketCap":17593072323},"quantilePoints":[{"date":"2025-04-17","current":-14.905978,"twenty":-15.065639,"median":-14.442293,"eighty":-11.334487,"marketCap":16635152800},{"date":"2025-04-25","current":-15.846935,"twenty":-16.770434,"median":-15.576033,"eighty":-14.349556,"marketCap":17719522633},{"date":"2025-05-02","current":-16.438538,"twenty":-16.715855,"median":-16.124153,"eighty":-14.985809,"marketCap":18420101638},{"date":"2025-05-09","current":-15.074661,"twenty":-16.551291,"median":-15.826729,"eighty":-15.074661,"marketCap":17010399982},{"date":"2025-05-16","current":-15.043786,"twenty":-16.438538,"median":-15.220044,"eighty":-14.405796,"marketCap":17114249721},{"date":"2025-05-23","current":-16.495727,"twenty":-16.438538,"median":-15.262587,"eighty":-14.582474,"marketCap":18822153243},{"date":"2025-05-30","current":-16.208434,"twenty":-16.401371,"median":-15.460562,"eighty":-14.726132,"marketCap":18575651704},{"date":"2025-06-06","current":-16.427701,"twenty":-16.438538,"median":-15.666395,"eighty":-14.905978,"marketCap":18874975001},{"date":"2025-06-13","current":-20.940103,"twenty":-16.693343,"median":-15.893657,"eighty":-15.005253,"marketCap":24069114577},{"date":"2025-06-20","current":-18.479443,"twenty":-18.428819,"median":-16.104695,"eighty":-15.043786,"marketCap":21199132371},{"date":"2025-06-27","current":-18.0452,"twenty":-18.863356,"median":-16.282988,"eighty":-15.074661,"marketCap":20758951051},{"date":"2025-07-04","current":-21.227749,"twenty":-18.942282,"median":-16.427701,"eighty":-15.074735,"marketCap":24421259633},{"date":"2025-07-11","current":-22.045806,"twenty":-19.683704,"median":-16.508309,"eighty":-15.190609,"marketCap":25336836779},{"date":"2025-07-18","current":-25.758166,"twenty":-20.839221,"median":-16.693343,"eighty":-15.21995,"marketCap":29580184704},{"date":"2025-07-25","current":-25.970367,"twenty":-21.539184,"median":-16.981252,"eighty":-15.260218,"marketCap":29932329760},{"date":"2025-08-01","current":-24.963588,"twenty":-22.267132,"median":-18.096065,"eighty":-15.298157,"marketCap":28594178547},{"date":"2025-08-08","current":-27.998627,"twenty":-24.402884,"median":-18.454131,"eighty":-15.429476,"marketCap":32150843612},{"date":"2025-08-15","current":-27.487815,"twenty":-25.397092,"median":-18.863356,"eighty":-15.513126,"marketCap":31516982512},{"date":"2025-08-22","current":-26.341915,"twenty":-25.761111,"median":-19.052333,"eighty":-15.750472,"marketCap":30108402288},{"date":"2025-08-29","current":-8.977182,"twenty":-25.761111,"median":-19.118727,"eighty":-15.513126,"marketCap":27784244918},{"date":"2025-09-05","current":-10.341403,"twenty":-25.547361,"median":-18.897362,"eighty":-15.21995,"marketCap":31974771084},{"date":"2025-09-12","current":-12.806892,"twenty":-25.484142,"median":-18.479443,"eighty":-15.036079,"marketCap":39669140558},{"date":"2025-09-19","current":-11.291493,"twenty":-25.397092,"median":-18.151913,"eighty":-14.569138,"marketCap":34950396808},{"date":"2025-09-26","current":-9.575685,"twenty":-25.265241,"median":-17.183112,"eighty":-14.242848,"marketCap":29562577451},{"date":"2025-10-03","current":-9.769092,"twenty":-25.225948,"median":-16.756996,"eighty":-13.467837,"marketCap":30231653057},{"date":"2025-10-10","current":-8.39875,"twenty":-25.201143,"median":-16.551291,"eighty":-12.508489,"marketCap":25953090627},{"date":"2025-10-17","current":-9.52866,"twenty":-25.090759,"median":-16.467132,"eighty":-11.127698,"marketCap":29421719428},{"date":"2025-10-24","current":-8.24833,"twenty":-24.683236,"median":-16.401371,"eighty":-10.383008,"marketCap":25477694801},{"date":"2025-10-31","current":-8.936138,"twenty":-24.228898,"median":-16.208434,"eighty":-10.01166,"marketCap":27643386896},{"date":"2025-11-07","current":-8.115895,"twenty":-24.0933,"median":-15.983588,"eighty":-9.661913,"marketCap":25090335240},{"date":"2025-11-14","current":-9.615008,"twenty":-24.036348,"median":-15.846935,"eighty":-9.533336,"marketCap":29809078990},{"date":"2025-11-21","current":-8.88084,"twenty":-23.659864,"median":-15.493415,"eighty":-9.411746,"marketCap":27520136126},{"date":"2025-11-28","current":-9.805814,"twenty":-23.032171,"median":-15.270261,"eighty":-9.358381,"marketCap":30496838785},{"date":"2025-12-05","current":-9.522579,"twenty":-22.810207,"median":-15.147164,"eighty":-9.358381,"marketCap":29666872704},{"date":"2025-12-12","current":-9.227769,"twenty":-22.078047,"median":-15.043786,"eighty":-9.232281,"marketCap":28801588916},{"date":"2025-12-19","current":-9.562517,"twenty":-22.024358,"median":-14.816055,"eighty":-9.195431,"marketCap":29916743432},{"date":"2025-12-24","current":-8.86445,"twenty":-21.960012,"median":-14.582474,"eighty":-9.185632,"marketCap":27819193982},{"date":"2026-01-02","current":-8.361415,"twenty":-21.780535,"median":-14.405796,"eighty":-9.071858,"marketCap":26343799029},{"date":"2026-01-09","current":-10.158481,"twenty":-21.573184,"median":-14.143758,"eighty":-9.138635,"marketCap":32085396254},{"date":"2026-01-16","current":-10.130227,"twenty":-21.338723,"median":-13.671075,"eighty":-9.159542,"marketCap":32100133626},{"date":"2026-01-23","current":-9.450777,"twenty":-21.128733,"median":-12.833558,"eighty":-9.159542,"marketCap":29918397524},{"date":"2026-01-30","current":-9.27281,"twenty":-20.989151,"median":-11.556174,"eighty":-9.159542,"marketCap":29489203537},{"date":"2026-02-06","current":-8.834279,"twenty":-20.864442,"median":-11.154997,"eighty":-9.026205,"marketCap":28165855410},{"date":"2026-02-13","current":-9.445101,"twenty":-20.730279,"median":-10.443288,"eighty":-9.076015,"marketCap":30286271904},{"date":"2026-02-20","current":-9.824687,"twenty":-20.674464,"median":-10.43817,"eighty":-9.09489,"marketCap":31458062186},{"date":"2026-02-27","current":-8.771359,"twenty":-20.006759,"median":-10.305855,"eighty":-9.047703,"marketCap":28393379910},{"date":"2026-03-06","current":-8.859488,"twenty":-19.896232,"median":-10.18539,"eighty":-8.969972,"marketCap":28447462538},{"date":"2026-03-13","current":-7.555838,"twenty":-19.630572,"median":-10.144354,"eighty":-8.935093,"marketCap":24373237865},{"date":"2026-03-20","current":-7.859442,"twenty":-19.432697,"median":-9.991099,"eighty":-8.867218,"marketCap":25256587462},{"date":"2026-03-27","current":-8.718949,"twenty":-19.118727,"median":-9.951719,"eighty":-8.854358,"marketCap":25617138318},{"date":"2026-04-02","current":-9.880216,"twenty":-19.012497,"median":-9.885599,"eighty":-8.850342,"marketCap":29168564250},{"date":"2026-04-10","current":-9.180446,"twenty":-18.964111,"median":-9.878849,"eighty":-8.85641,"marketCap":27311727342},{"date":"2026-04-17","current":-9.417233,"twenty":-18.904163,"median":-9.820225,"eighty":-8.842311,"marketCap":28027927148},{"date":"2026-04-24","current":-8.878352,"twenty":-18.860571,"median":-9.805814,"eighty":-8.846908,"marketCap":26425587896},{"date":"2026-04-30","current":-8.372511,"twenty":-18.781003,"median":-9.783435,"eighty":-8.82699,"marketCap":24926391864},{"date":"2026-05-08","current":-7.738947,"twenty":-18.469318,"median":-9.736996,"eighty":-8.785939,"marketCap":23120131584},{"date":"2026-05-15","current":-6.609967,"twenty":-18.384608,"median":-9.691452,"eighty":-8.751075,"marketCap":20699742808},{"date":"2026-05-22","current":-6.440114,"twenty":-18.185423,"median":-9.652725,"eighty":-8.708072,"marketCap":20121739519},{"date":"2026-05-29","current":-6.506712,"twenty":-18.096065,"median":-9.620334,"eighty":-8.669056,"marketCap":20400514838},{"date":"2026-06-05","current":-5.374082,"twenty":-18.0452,"median":-9.575685,"eighty":-8.511806,"marketCap":16873830092},{"date":"2026-06-12","current":-5.36331,"twenty":-17.183112,"median":-9.557279,"eighty":-8.481744,"marketCap":16828616185},{"date":"2026-06-18","current":-5.321722,"twenty":-16.860136,"median":-9.537613,"eighty":-8.412993,"marketCap":16738188371},{"date":"2026-06-26","current":-4.703556,"twenty":-16.761475,"median":-9.522579,"eighty":-8.375473,"marketCap":14721648119},{"date":"2026-07-03","current":-6.212828,"twenty":-16.718804,"median":-9.508222,"eighty":-8.310046,"marketCap":19460065572},{"date":"2026-07-10","current":-6.457487,"twenty":-16.608112,"median":-9.462457,"eighty":-8.218812,"marketCap":20201573647},{"date":"2026-07-17","current":-6.192643,"twenty":-16.533051,"median":-9.445101,"eighty":-8.097368,"marketCap":19441980010},{"date":"2026-07-24","current":-6.744145,"twenty":-16.505793,"median":-9.428231,"eighty":-7.995787,"marketCap":21178194038},{"date":"2026-07-31","current":-5.225281,"twenty":-16.472851,"median":-9.409879,"eighty":-7.856069,"marketCap":16439776585},{"date":"2026-08-07","current":-5.555188,"twenty":-16.434203,"median":-9.398864,"eighty":-7.73561,"marketCap":17511664790},{"date":"2026-08-14","current":-5.519506,"twenty":-16.417169,"median":-9.342917,"eighty":-7.473767,"marketCap":17421211976},{"date":"2026-08-21","current":-5.561665,"twenty":-16.354018,"median":-9.310353,"eighty":-6.918832,"marketCap":17593072323}],"updateTime":1787476991967},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09606\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2626812591","title":"Dualitybio Announces China Nmpa Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic Her2-Positive Adult Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2626812591","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626812591?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:56","pubTimestamp":1775735770,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nTUA9T0R2M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000500386.USD","09606","HK0000252152.HKD","LU2543165471.USD","BK1161","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150883471","title":"DUALITYBIO-B's New Drug Application for HER2-Positive Breast Cancer Accepted by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1150883471","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150883471?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:54","pubTimestamp":1775732071,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) has announced that its Biologics License Application (BLA) for DB-1303/BNT323 has been accepted by the National Medical Products Administration (NMPA). This submission is based...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09606","LU2543165471.USD","HK0000500386.USD","BK4566","BK4118","DB","BK4552","HK0000252152.HKD","BK4585","BK4588","HK0000252160.HKD","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626186811","title":"BRIEF-Duality Biotherapeutics Says NMPA Accepts Biologics License Application For Db-1303/Bnt323","url":"https://stock-news.laohu8.com/highlight/detail?id=2626186811","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626186811?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:53","pubTimestamp":1775731991,"startTime":"0","endTime":"0","summary":"BRIEF-Duality Biotherapeutics Says NMPA Accepts Biologics License Application For Db-1303/Bnt323April 9  - Duality Biotherapeutics Inc 9606.HK:NMPA ACCEPTS BIOLOGICS LICENSE APPLICATION FOR DB-1303/BNT323 IN HER2-POSITIVE BREAST CANCERFurther company coverage: 9606.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S0CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","HK0000252160.HKD","HK0000500386.USD","BK1161","HK0000252152.HKD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626518507","title":"Duality Biotherapeutics Inc - Nmpa Accepts Biologics License Application for Db-1303/Bnt323 in Her2-Positive Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2626518507","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626518507?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:49","pubTimestamp":1775731759,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S0CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09606","HK0000252160.HKD","LU2543165471.USD","BK1161","HK0000500386.USD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626185005","title":"Duality Biotherapeutics says China NMPA accepts BLA for DB-1303 in HER2+ breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2626185005","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626185005?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:49","pubTimestamp":1775731759,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics secured NMPA acceptance of biologics license application for DB-1303/BNT323 in unresectable or metastatic HER2-positive breast cancer in adults.Filing was supported by Phase III DB-1303-O-3001 data showing statistically significant progression-free survival improvement versus Roche’s Kadcyla .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duality Biotherapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL7bhTxC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","HK0000252160.HKD","HK0000500386.USD","BK1161","HK0000252152.HKD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172387094","title":"Duality Biotherapeutics Sets 24–29 April 2026 Book Closure for Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1172387094","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172387094?lang=en_us&edition=fundamental","pubTime":"2026-04-09 16:41","pubTimestamp":1775724115,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. will convene an Extraordinary General Meeting (EGM) at 9:00 a.m. on Wednesday, 29 April 2026, in the Board Room, 11/F, Building A, No. 868 Yinghua Road, Pudong New Area,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626027389","title":"Duality Biotherapeutics announces extraordinary general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2626027389","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626027389?lang=en_us&edition=fundamental","pubTime":"2026-04-09 16:38","pubTimestamp":1775723893,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics scheduled an extraordinary general meeting in Shanghai on April 29, 2026.Share register closure set for April 24–29, 2026 to determine shareholder eligibility for the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duality Biotherapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL2Cgwcs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09606","HK0000500386.USD","HK0000252160.HKD","LU2543165471.USD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149528263","title":"HK Pharma Stocks Gained. CSPC Pharma Up 13%; Lepu Bio Up 7%; Hengrui Pharma And Junshi Bio Up 6%; HBM, Beigene, Sihuan Pharm Up 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149528263","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149528263?lang=en_us&edition=fundamental","pubTime":"2026-03-27 14:14","pubTimestamp":1774592089,"startTime":"0","endTime":"0","summary":"HK Pharma Stocks Gained. CSPC Pharma Up 13%; Lepu Bio up 7%; Hengrui Pharma and Junshi Bio Up 6%; HBM, Beigene, $Sihuan Pharm(00460)$ Up 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","02157","09688","02268","06978","09966","02359","02269","02137","01276","01093","01672","09606","09995","03347","06606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139469969","title":"DualityBio-B Maintains Outperform Rating with HK$430 Target from CICC","url":"https://stock-news.laohu8.com/highlight/detail?id=1139469969","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139469969?lang=en_us&edition=fundamental","pubTime":"2026-03-27 10:36","pubTimestamp":1774578988,"startTime":"0","endTime":"0","summary":"CICC has reiterated its Outperform rating on DUALITYBIO-B (09606) with an unchanged target price of HK$430, implying a 63.4% upside potential from the current share price, based on a DCF valuation...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","LU2543165471.USD","BK1161","HK0000252160.HKD","HK0000252152.HKD","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178986582","title":"Stock Track | Duality Biotherapeutics Soars 5% Intraday as Analysts Boost Estimates After Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1178986582","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178986582?lang=en_us&edition=fundamental","pubTime":"2026-03-27 10:17","pubTimestamp":1774577840,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics (HKG:09606) saw its stock price soar 5.00% during intraday trading on Friday, following the release of its annual results and subsequent analyst updates.The biotech company's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622135258","title":"Earnings Update: Duality Biotherapeutics, Inc. (HKG:9606) Just Reported And Analysts Are Boosting Their Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2622135258","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622135258?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:05","pubTimestamp":1774562708,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. ( HKG:9606 ) shareholders are probably feeling a little disappointed, since its shares...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/earnings-update-duality-biotherapeutics-inc-hkg9606-just-rep","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/earnings-update-duality-biotherapeutics-inc-hkg9606-just-rep","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148472362","title":"HK Pharma Stocks Gained. XuanzhuBio Up 9%; Xtalpi, Lepu Bio And Ascletis Up 6%; Akeso Up 5%; Skb Bio Up 4%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1148472362","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148472362?lang=en_us&edition=fundamental","pubTime":"2026-03-26 09:54","pubTimestamp":1774490045,"startTime":"0","endTime":"0","summary":"HK Pharma Stocks Gained. XuanzhuBio up 9%; Xtalpi, Lepu Bio and Ascletis up 6%; Akeso up 5%; Skb Bio up 4%. ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","09606","09688","06978","01672","02575","03347","02137","03759","06606","02269","09966","02359","02157","02268","02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621548880","title":"Dualitybio (9606.HK) Announces 2025 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2621548880","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621548880?lang=en_us&edition=fundamental","pubTime":"2026-03-24 15:43","pubTimestamp":1774338231,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUA5JTWZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000252152.HKD","BK1161","LU2543165471.USD","HK0000500386.USD","HK0000252160.HKD","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621054815","title":"Press Release: DualityBio (9606.HK) Announces 2025 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2621054815","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621054815?lang=en_us&edition=fundamental","pubTime":"2026-03-24 15:43","pubTimestamp":1774338180,"startTime":"0","endTime":"0","summary":"HONG KONG, March 24, 2026 /PRNewswire/ -- Duality Biotherapeutics, Inc. , a leading global clinical-stage innovative biopharmaceutical company, today announced its first annual results since listing on April 15, 2025 , providing a comprehensive update on its global clinical pipeline and corporate operations.During the reporting period, the Company achieved total revenue of RMB1.852 billion , providing a solid financial foundation for the continuous advancement of business. R&D investment remained at a high level, with annual R&D expenses reaching RMB838 million; the adjusted loss for the year was RMB389 million . The Company maintained a healthy cash flow position, with cash and bank balances of RMB3.325 billion as of the end o","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4118","BK4585","BK4552","LU2543165471.USD","09606","BK1161","DB","HK0000252160.HKD","HK0000500386.USD","HK0000252152.HKD","BK4588","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148394372","title":"Stock Track | Duality Biotherapeutics Plummets 5.04% Intraday on Widened 2025 Loss and Revenue Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1148394372","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148394372?lang=en_us&edition=fundamental","pubTime":"2026-03-24 11:09","pubTimestamp":1774321752,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics (09606.HK) shares plummeted 5.04% during intraday trading on Tuesday, following the release of its full-year 2025 financial results.The biopharmaceutical company reported a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156264604","title":"HK Pharma Stocks Gained. Wuxi XDC Up 8%; Wuxi AppTec Up 7%; Transthera And HBM Up 5%; Keymed Bio And Innocare Up 4%; Wuxi Bio And Remegen Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156264604","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156264604?lang=en_us&edition=fundamental","pubTime":"2026-03-24 09:46","pubTimestamp":1774316807,"startTime":"0","endTime":"0","summary":"HK Pharma Stocks Gained. Wuxi XDC up 8%; Wuxi AppTec up 7%; Transthera and HBM up 5%; Keymed Bio and Innocare up 4%; Wuxi Bio and Remegen up 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137","02359","09966","02162","09688","02268","06606","09606","06978","02269","09995","03347","03759","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621707467","title":"BRIEF-Duality Biotherapeutics FY Revenue Rmb1.85 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2621707467","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621707467?lang=en_us&edition=fundamental","pubTime":"2026-03-23 23:31","pubTimestamp":1774279896,"startTime":"0","endTime":"0","summary":"BRIEF-Duality Biotherapeutics FY Revenue Rmb1.85 BillionMarch 23 (Reuters) - Duality Biotherapeutics Inc 9606.HK:FY  REVENUE RMB1.85 BILLIONLOSS FOR YEAR ATTRIBUTABLE RMB2.59 BILLIONFurther company coverage: 9606.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B09R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","HK0000252160.HKD","LU2543165471.USD","BK1161","HK0000500386.USD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621570110","title":"BRIEF-Duality Biotherapeutics Inc Says Si Wen Tendered Resignation As Exec Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2621570110","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621570110?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:01","pubTimestamp":1774274511,"startTime":"0","endTime":"0","summary":"BRIEF-Duality Biotherapeutics Inc Says Si Wen Tendered Resignation As Exec DirectorMarch 23  - Duality Biotherapeutics 9606.HK:SI WEN TENDERED HER RESIGNATION AS AN EXECUTIVE DIRECTORHUA HAIQING HAS BEEN APPOINTED AS AN EXECUTIVE DIRECTORZHANG SHAOREN HAS BEEN APPOINTED AS CFOFurther company coverage: 9606.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0S6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","09606","HK0000252152.HKD","HK0000252160.HKD","BK1161","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141225275","title":"DUALITYBIO-B Reports 2025 Revenue of Approximately 18.52 Billion Yuan, Marking Significant Pipeline and Operational Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1141225275","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141225275?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:58","pubTimestamp":1774270703,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) announced its 2025 financial results, achieving revenue of approximately 18.52 billion yuan and a gross profit of about 5.89 billion yuan. Research and development expenses were...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","LU2543165471.USD","HK0000252152.HKD","BK1161","HK0000500386.USD","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113759417","title":"DualityBio Posts Wider 2025 Loss on Fair-Value Impact; Core ADC Programs Advance Toward Commercial Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=1113759417","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113759417?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:41","pubTimestamp":1774269709,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics (DualityBio, 09606) reported audited results for the year to 31 December 2025: Financial performance   • Revenue slipped 4.60 % to RMB 1.85 billion, reflecting lower milestone...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":136,"code":"91000000","status":"200"}]}}